97617658 - EQUITABLE BREAKTHROUGHS IN MEDICINE DEVELOPMENT

Information

  • Trademark
  • 97617658
  • Serial Number
    97617658
  • Registration Number
    7634670
  • Filing Date
    October 03, 2022
    3 years ago
  • Registration Date
    December 31, 2024
    a year ago
  • Transaction Date
    December 31, 2024
    a year ago
  • Status Date
    December 31, 2024
    a year ago
  • Published for Opposition Date
    October 10, 2023
    2 years ago
  • Location Date
    December 11, 2024
    a year ago
  • First Use Anywhere Date
    July 01, 2022
    3 years ago
  • First Use In Commerce Date
    July 01, 2022
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SUE, ABIGAIL
  • Attorney Docket Number
    Y01152014200
    Attorney Name
    Christina M. Licursi
    Law Office Assigned Location Code
    M80
  • Owners
Mark Drawing Code
4
Mark Identification
EQUITABLE BREAKTHROUGHS IN MEDICINE DEVELOPMENT
Case File Statements
  • GS0411: Educational services, namely, community-based educational programs and educational content to enhance clinical trial diversity; educational services, namely, training educators in the field of clinical research through community engagements, workshops and seminars; retention services, namely, analysis and reach-out to potential participants for the purpose of recruiting participants in clinical trials for the testing of clinical drugs and treatments
  • GS0351: Business consulting and management in the field of clinical trials; recruiting services, namely, analysis and reach-out to potential participants for the purpose of recruiting participants in clinical trials for the testing of clinical drugs and treatments
  • GS0421: Clinical research and investigation in the field of clinical trials for the testing of clinical drugs and treatments; providing medical and scientific research information in the field of clinical drug development and clinical trials; consulting services for others in the field of design, planning, and implementation project management of clinical trials; providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects related to equitable access and diversity of clinical research participation
Case File Event Statements
  • 10/20/2022 - 3 years ago
    1 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/17/2023 - 2 years ago
    2 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/18/2023 - 2 years ago
    3 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/18/2023 - 2 years ago
    4 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/18/2023 - 2 years ago
    5 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/31/2023 - 2 years ago
    6 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/31/2023 - 2 years ago
    7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/1/2023 - 2 years ago
    8 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/6/2023 - 2 years ago
    9 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 9/6/2023 - 2 years ago
    10 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 9/6/2023 - 2 years ago
    11 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/6/2023 - 2 years ago
    12 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/6/2023 - 2 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/20/2023 - 2 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/10/2023 - 2 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/10/2023 - 2 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/5/2023 - 2 years ago
    17 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/3/2024 - 2 years ago
    20 - USE AMENDMENT FILED Type: IUAF
  • 6/3/2024 - 2 years ago
    18 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 7/13/2024 - a year ago
    19 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 7/16/2024 - a year ago
    21 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 8/26/2024 - a year ago
    23 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/26/2024 - a year ago
    24 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/6/2024 - a year ago
    25 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/11/2024 - a year ago
    30 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 12/11/2024 - a year ago
    28 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/11/2024 - a year ago
    27 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/11/2024 - a year ago
    29 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 12/11/2024 - a year ago
    26 - ASSIGNED TO LIE Type: ALIE
  • 12/31/2024 - a year ago
    31 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/31/2024 - a year ago
    32 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 8/26/2024 - a year ago
    22 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT